Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Mechanically ventilated intensive care patients will be sampled for a small amount of exhaled breath condensate from the ventilator circuit and for venous blood.
Proteomic analysis of the exhaled breath condensate will be performed using mass spectrometry and in the blood sample, corresponding changes in the DNA, RNA, proteins, and metabolites will be studied. Resulting profiles will be correlated with routinely monitored parameters in order to identify patterns corresponding to various pathologies in order to enable their early detection.
Exhaled breath condensate (EBC) is a product of gas exchange in the lungs. It contains plethora of substances of possible diagnostic value and its composition is likely to change rapidly in response to the development of pathological conditions, especially in the lungs.
Mechanically ventilated intensive care patients with various pathological conditions will be sampled for a small amount of EBC from the ventilator circuit and for venous blood. A sampling method not affecting relevant parameters of mechanical ventilation will be developed and standardised.
EBC samples will be frozen and after processing, proteomic analyses will be performed using mass spectrometry. In the blood sample, corresponding changes in the DNA, RNA, proteins, and metabolites will be studied using molecular biological methods. Resulting profiles will be correlated with routinely monitored parameters (such as inflammation markers, microbiological findings and mechanical ventilation parameters) with the aim of finding patterns corresponding to the early stages of various pathological conditions focusing on lung tissue. Identification of patterns specific to initial stages of lung and other organ pathologies would enable their early treatment possibly shortening mechanical ventilation/ICU stay and reducing morbidity/mortality.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Mechanically ventilated patients with primary or secondary lung injury | Mechanically ventilated patients with primary or secondary lung injury due to various pathologies. Patients will be treated at intensive care units (ICU). |
| |
| Mechanically ventilated patients without lung injury | Mechanically ventilated patients without lung injury, with various pathologies. Patients will be treated at intensive care units (ICU). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Proteomic analysis of exhaled breath condensate | Diagnostic Test | Mechanically ventilated intensive care patients will be sampled for exhaled breath condensate from the ventilator circuit. |
| Measure | Description | Time Frame |
|---|---|---|
| Comparison of proteomic patterns of the exhaled breath condensate in mechanically ventilated intensive care patients. | Proteomic patterns of the exhaled breath condensate will be studied in mechanically ventilated intensive care patients. The results will be analysed and compared with the aim to identify patterns specific for the pathological conditions. | January 2024 - December 2029 |
| Measure | Description | Time Frame |
|---|---|---|
| Correlation of exhaled breath condensate patterns with molecular biological findings in venous blood - DNA | Venous blood sample will be analysed employing targeted analyses of DNA. The results will be correlated to proteomic patterns obtained from the exhaled breath condensate. | January 2024 - December 2029 |
Not provided
Inclusion Criteria:
Intensive care setting Mechanical ventilation Ventilator/ventilator circuit technically suitable for sampling of exhaled breath condensate
Exclusion Criteria:
Mechanical ventilation challenging to the extent that the insertion of the sampling kit into the ventilator circuit would substantially increase the risk for respiratory deterioration
Not provided
Not provided
Not provided
Mechanically ventilated intensive care patients with or without acute hypoxemic respiratory failure
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Emil Berta, MD PhD | Contact | +420585632111 | e.berta@upol.cz | |
| Karel Axmann, MD | Contact | +420588445356 | karel.axmann@fnol.cz |
| Name | Affiliation | Role |
|---|---|---|
| Emil Berta, MD PhD | IMTM, Palacky University in Olomouc, Faculty of Medicine and Dentistry | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Institute of Molecular and Translational Medicine, Palacky University | Recruiting | Olomouc | 77900 | Czechia |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D016638 | Critical Illness |
| D055370 | Lung Injury |
| ID | Term |
|---|---|
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D008171 | Lung Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Venous blood
|
| Correlation of exhaled breath condensate patterns with molecular biological findings in venous blood - RNA |
Venous blood sample will be analysed employing targeted analyses of RNA. The results will be correlated to proteomic patterns obtained from the exhaled breath condensate. |
| January 2024 - December 2029 |
| Correlation of exhaled breath condensate patterns with molecular biological findings in venous blood - proteins | Venous blood sample will be analysed employing targeted analyses of proteins. The results will be correlated to proteomic patterns obtained from the exhaled breath condensate. | January 2024 - December 2029 |
| Correlation of exhaled breath condensate patterns with molecular biological findings in venous blood - metabolites | Venous blood sample will be analysed employing targeted analyses of metabolites. The results will be correlated to proteomic patterns obtained from the exhaled breath condensate. | January 2024 - December 2029 |
| University Hospital Olomouc | Recruiting | Olomouc | 77900 | Czechia |
|
| D012140 | Respiratory Tract Diseases |
| D013898 | Thoracic Injuries |
| D014947 | Wounds and Injuries |